12th Annual UCLA-Mellinkoff Gastroenterology and Hepatology Symposium

Friday, March 15, 2024, 7:00 AM - Saturday, March 16, 2024, 5:00 PM, UCLA Meyer & Renee Luskin Conference Center, Los Angeles, CA

Live, virtual and in-person conference. The 12th Annual UCLA-Mellinkoff Gastroenterology and Hepatology Symposium is designed to offer healthcare professionals evidence-based and integrative approaches to treat common GI disorders that can easily be implemented into practice and have significant impact on patient outcomes. An endoscopy forum with video and live cases will also show complex cases and new technology. New to the program is an in-person workshop with visual and interactive methods to teach the process of patient-centered care to improve communication skills, patient-provider relationship, and patient satisfaction. Interactive, case-based presentations and panel discussions by experts in their field will engage attendees and enhance this learning experience.

Course Fee

In-Person
$400 - MD/DO
$350 - UCLA GI fellow alumni
$300 - Other healthcare professions
Complimentary - Fellow/Trainees - email [email protected]

Virtual
$200 - MD/DO
$200 - Other healthcare professions
Complimentary - Fellow/Trainees - email [email protected]

*Those who choose the in-person option can also access the virtual platform. If the attendee decides to change from in-person to virtual only, this must be received via email by March 4, 2024 to [email protected] in order to receive a refund for the difference. We do not offer single day rates.

Refunds
Cancellations must be received by email by March 4, 2024 to [email protected] and will be subject to a $75 processing fee. No refunds will be granted after that date. If, for any reason, the course is canceled, discontinued, or rescheduled, a full refund will be provided.

Course Recording
All registrants will be provided the opportunity to review selected recorded sessions following the conference. 
The recorded sessions are not approved for Continuing Education (CE) credit. 

1. Discuss therapeutic options and on-treatment management strategies for patients with liver disorders
2. Discuss current goals of therapy and management strategies utilizing a holistic approach to treat disorders of the gut-brain interaction (DGBI)
3. Apply the newest therapeutic strategies to better diagnose, classify and achieve remission in patients with Crohn's disease and ulcerative colitis
4. Describe treatment options and varying endoscopic approaches to managing pancreatic disorders
5. Understand the medical and endoscopic management options for the treatment of esophageal disorders
6. Understand the relationship between food and nutrition, and the foundational science involved in developing nutrition plans for GI disorders
7. Implement practice skills and techniques to improve clinical-patient communication to enhance health outcomes

 

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 15.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Nurses
The California State Board of Registered Nursing accepts courses approved by the AMA PRA Category 1 Credits™. as meeting the continuing education requirements for license renewal. Nurses from states other than California should inquire with their local State Board for specific continuing education policies. Nursing participants, who attend both days in full, will be awarded 15.75 CMEs. Partial credit is not available. For more information, please visit the California BRN website or contact Kathleen Feldman, MSN, RN, NPD-BC, at [email protected]

AMA PRA Category 1 Credits™ (15.75 hours), ABIM MOC Part 2 (15.75 hours), Non-Physician Attendance (15.75 hours)

UCLA Meyer and Renee Luskin Conference Center
425 Westwood Plaza, Los Angeles, CA 90095

The UCLA Meyer and Renee Luskin Conference Center and its adjoining hotel is a LEED Platinum-certified property enhanced by leading edge resources. It’s central location makes it a wonderful base from which to explore many exciting cultural opportunities, including the UCLA Fowler Museum, Geffen Playhouse, UCLA Athletic Hall of Fame and The Getty Museum as well as shopping and dining in nearby Beverly Hills.
luskinconferencecenter.ucla.edu

Overnight Accommodations
We urge you to make reservations early. A limited block of rooms, at a special rate of $319 + tax has been reserved. The rates will be honored three days pre-and post-meeting based on group room availability. Internet access is complimentary to overnight guests.
To receive this rate, you must make your reservation before the room block is filled and by the expiration date of February 20, 2024. Attendees are responsible for their own reservations. The standard hotel reservation cancellation policy will apply to the individual reservations, unless otherwise specified.

To reserve a room, call 855-522-8252 and ask for group code: LG2403MELB. Or make a reservation online at bit.ly/3NohYuz

Conference Parking
From the 405 freeway, exit Wilshire Blvd., East toward Westwood. Turn left on Westwood Blvd., travel past Charles E. Young Dr. South and turn left on Structure 8 driveway. Drive up the ramp to the rooftop level to park. Pay stations are located up on the roof top. All day self parking is $15. There is a convenient walkway/bridge connecting Parking Structure8 (on level 3) to the Luskin Conference Center Property. The Luskin Conference Center is located at Westwood Plaza and Strathmore Place.

Overnight self parking is available at The Luskin Conference Center at $35 per night on a first come, first served basis.
There is also self parking available at Parking Structure 8 at $30 per night.

All parking rates are subject to change. For additional information, please visit: luskinconferencecenter.ucla.edu/about/campus-map-parking/

 

Mitigation of Relevant Financial Relationships

The Accreditation Council for Continuing Medical Education (ACCME), Standards for Integrity and Independence mandates that the accreditation manages all identified relevant financial relationship(s) before the program and adequately discloses relationships to learners. The David Geffen School of Medicine at UCLA adheres to the ACCME Standards for Integrity and Independence in accredited continuing education.

The individuals below have been identified as having a position to influence the content of this educational activity. As such, they have disclosed the absence or presence of a relevant financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All of the relevant financial relationships for these individuals have been mitigated.

 

We regret to inform you that this course has reached full capacity. However, if you would like to secure a place on the waiting list, kindly reach out to us via email at [email protected].

 

Exhibiting at this event operates on a first-come, first-serve basis.

1. Complete the provided form by downloading and electronically signing Letter Of Agreement

2. Submit to the email address mentioned below.

3.Use the "Exhibit At This Event" button to process your payment. 

W9 Form Exhibit at this Event

Acknowledgments
This program is supported in part by educational grants and exhibitors from the following:

Exhibitors: 

Abbvie
Boston Scientific
Bristol Myers Squibb
Castle Biosciences
Cook Medical
EndoGastric Solutions
Erbe
FUJIFILM Healthcare Americas Corporation
GILEAD SCIENCES
Intercept Pharmaceuticals, Inc.
Ironwood Pharma
Johnson & Johnson Innovative Medicine
Mallinckrodt Pharmaceuticals
Medtronic
Micro Tech Endoscopy
Neptune Medical
Olympus America, Inc
Ovesco
Pfizer
Phathom Pharmaceuticals
Prometheus Laboratories
QOL Medical
Salix Pharmaceuticals
Sanofi – Regeneron
STERIS
Takeda

 

Grants: 

Cook Medical
Erbe
FUJIFILM Healthcare Americas Corporation
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC- both are Johnson & Johnson companies
Medtronic
Merit Medical Systems, Inc.
Olympus Corporation of the Americas
Ovesco
PENTAX of America, Inc.
Salix Pharmaceuticals, A Division of Bausch Health US, LLC
STERIS